Papers: 18 Apr 2014 - 25 Apr 2014
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
LOGISMOS-B: Layered Optimal Graph Image Segmentation of Multiple Objects and Surfaces for the Brain.
A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Internet-based home training is capable to improve balance in multiple sclerosis: a comparative trial with hippotherapy.
Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy.
Adherence in multiple sclerosis (ADAMS): Classification, relevance, and research needs. A meeting report.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Reply: Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.
Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
An update on neuro-ophthalmology of multiple sclerosis: the visual system as a model to study multiple sclerosis.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis.
Fiber-Optic Bronchoscopy and Volume-Cycled Mouthpiece Ventilation for a Patient with Multiple Sclerosis and Ventilatory Failure.
Autoimmune priming tissue attack and chronic inflammation - The three stages of rheumatoid arthritis.
Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination During Proteasomal Degradation.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version.
Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.